Imidaprilat API is the active metabolite of Imidapril, a pharmaceutical-grade Angiotensin-Converting Enzyme (ACE) inhibitor used in cardiovascular research and antihypertensive pharmaceutical development. It inhibits the conversion of angiotensin I to angiotensin II, resulting in vasodilation, reduced peripheral vascular resistance, decreased aldosterone secretion, and effective blood pressure control.
Imidaprilat plays a crucial role in ACE inhibitor pharmacology and is widely utilized in cardiovascular research, bioequivalence studies, impurity profiling, and pharmaceutical development. It demonstrates potent and long-lasting inhibition of ACE activity, supporting effective management of hypertension and related cardiovascular disorders.
Manufactured under WHO-GMP-certified facilities, our Imidaprilat API is produced with advanced quality systems to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch is accompanied by complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Imidaprilat API is used in cardiovascular pharmaceutical research, ACE inhibitor development, bioequivalence studies, and antihypertensive formulations.
Imidaprilat inhibits the angiotensin-converting enzyme (ACE), reducing angiotensin II formation, relaxing blood vessels, lowering blood pressure, and decreasing cardiac workload.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Imidaprilat API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp